BioNTech SE (BNTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:18AM EDT. Market open.
| Previous close | 133.68 |
| Open | 134.90 |
| Bid | 134.72 x 800 |
| Ask | 134.97 x 800 |
| Day's range | 133.54 - 135.90 |
| 52-week range | 117.08 - 189.07 |
| Volume | |
| Avg. volume | 679,476 |
| Market cap | 32.525B |
| Beta (5Y monthly) | 0.24 |
| PE ratio (TTM) | 3.09 |
| EPS (TTM) | 43.43 |
| Earnings date | 27 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 02 Jun 2022 |
| 1y target est | 216.39 |
- Simply Wall St.
BioNTech SE's (NASDAQ:BNTX) largest shareholders are private equity firms with 43% ownership, individual investors own 20%
Key Insights The considerable ownership by private equity firms in BioNTech indicates that they collectively have a...
- Yahoo Finance
Moderna CEO faces Sen. Sanders in COVID-19 vaccine pricing hearing Wednesday
Moderna CEO Stéphane Bancel is set to face Sen. Bernie Sanders to defend the company's fast growth and planned price hike of its COVID-19 vaccine.
- Zacks
Sarepta Therapeutics (SRPT) Soars 7.1%: Is Further Upside Left in the Stock?
Sarepta Therapeutics (SRPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
© 2023 Yahoo. All rights reserved.
